Genzyme Posts Disappointing Q4 Results; Refuses to Comment on Sanofi

12.01.2011 - Genzyme, the subject of an $18.5 billion hostile takeover bid from Sanofi-Aventis SA, posted preliminary Q4 earnings that fell short of Wall Street forecasts and cut its earnings...